as a prenatal challenge: megacystis‐microcolonintestinal hypoperistalsis syndrome in a male fetus. Ultrasound Obstet Gynecol 2013; 41:345.180 180. Talabani H, Dreux S, Luton D, et al. Fetal anal incontinence evaluated by amniotic fluid digestive enzyme assay in myelomeningocele spina bifida. Pediatr Res 2005; 58:766.
181 181. Potier M, Melancon SB, Dallaire L. Fetal intestinal disaccharidases in human amniotic fluid. Biomedicine 1976; 25:167.
182 182. Arey LB. Developmental anatomy: a textbook and laboratory manual of embryology, 7th edn. Philadelphia: WB Saunders, 1965.
183 183. Gitlin D, Kumate J, Morales C, et al. The turnover of amniotic fluid protein in the human conceptus. Am J Obstet Gynecol 1972; 113:632.
184 184. Mulivor RA, Mennuti MT, Harris H. Origin of the alkaline phosphatases in amniotic fluid. Am J Obstet Gynecol 1979; 135:77.
185 185. Pocknee RC, Abramovich DR. Origin and levels of trypsin in amniotic fluid throughout pregnancy. Br J Obstet Gynaecol 1982; 89:142.
186 186. van Diggelen OP, Janse HC, Kleijer WJ. Disaccharidases in amniotic fluid as possible prenatal marker for cystic fibrosis. Lancet 1983; i:817.
187 187. Jarmas AL, Weaver DD, Padilla LM, et al. Hirschsprung disease: etiologic implications of unsuccessful prenatal diagnosis. Am J Med Genet 1983; 16:163.
188 188. Carbarns NJ, Gosden C, Brock DJ. Microvillar peptidase activity in amniotic fluid: possible use in the prenatal diagnosis of cystic fibrosis. Lancet 1983; i:329.
189 189. Brock DJ. Amniotic fluid alkaline phosphatase isoenzymes in early prenatal diagnosis of cystic fibrosis. Lancet 1983; ii:941.
190 190. Szabo M, Munnich A, Teichmann F, et al. Discriminant analysis for assessing the value of amniotic fluid microvillar enzymes in the prenatal diagnosis of cystic fibrosis. Prenat Diagn 1990; 10:761.
191 191. Morin PR, Potier M, LaSalle R, et al. Amniotic‐fluid disaccharidases in the prenatal detection of cystic fibrosis. Lancet 1983; ii:621.
192 192. Janlanko H, Aula P. Decrease in gamma‐glutamyl transpeptidase activity in early amniotic fluid in fetal trisomy 18 syndrome. Br Med J 1982; 284:1593.
193 193. Jalanko H. Developmental changes in gamma‐glutamyl transpeptidase in human amniotic fluid. Oncodev Biol Med 1983; 4:253.
194 194. Moniz C, Nicolaides KH, Keys D, et al. Gammaglutamyl transferase activity in fetal serum, maternal serum, and amniotic fluid during gestation. J Clin Pathol 1984; 37:700.
195 195. Brock DJ, Bedgood D, Hayward C, et al. Amniotic fluid microvillar enzyme activities in the early detection of fetal abnormalities. Prenat Diagn 1984; 4:261.
196 196. Davidson GP, Cutz E, Hamilton JR, et al. Familial enteropathy: a syndrome of protracted diarrhea from birth, failure to thrive, and hypoplastic villus atrophy. Gastroenterology 1978; 75:783.
197 197. Abramsky O, Brenner T, Lisak RP, et al. Significance in neonatal myasthenia gravis of inhibitory effect of amniotic fluid on binding of antibodies to acetylcholine receptor. Lancet 1979; ii:1333.
198 198. Brown CL, Colden KA, Hume RF, et al. Faint and positive amniotic fluid acetylcholinesterase with a normal sonogram. Am J Obstet Gynecol 1996; 175:1000.
199 199. Symonds EM, Williams SS, Cellier KM. Maternal and fetal influences on the acid‐base balance of human amniotic fluid. Obstet Gynecol 1971; 37:742.
200 200. Jauniaux E, Watson A, Burton G. Evaluation of respiratory gases and acid‐base gradients in human fetal fluids and uteroplacental tissue between 7 and 16 weeks' gestation. Am J Obstet Gynecol 2001; 184:998.
201 201. Vrachnis N, Malamitsi‐Puchner A, Samoli E, et al. Elevated mid‐trimester amniotic fluid ADAM‐8 concentrations as a potential risk factor for preterm delivery. J Soc Gynecol Investig 2006; 13:186.
202 202. Yamashiro C, Kanenishi K, Akiyama M, et al. Adrenomedullin concentrations in early 2nd‐trimester amniotic fluid: relation to preterm delivery and fetal growth at birth. Gynecol Obstet Invest 2002; 54:99.
203 203. Gulbis B, Jauniaux E, Cotton F, et al. Protein and enzyme patterns in the fluid cavities of the first trimester gestational sac: relevance to the absorptive role of secondary yolk sac. Mol Hum Reprod 1998; 4:857.
204 204. Jalanko H, Heikinheimo M, Ryynanen M, et al. Alkaline phosphatase activity in amniotic fluid in pregnancies with fetal disorders. Prenat Diagn 1983; 3: 303.
205 205. Evans HE, Glass L, Mandl I. Alpha1‐antitrypsin concentration in amniotic fluid. Biol Neonate 1975; 27:232.
206 206. Kleinbauer D, Klink F, Wagner T, et al. Blutgerinnung und Fibrinolyse Faktor‐Aktivitäten in der Amnionflüssigkeit. [Blood coagulation and fibrinolytic factor activities in the amniotic fluid]. Geburtshilfe Frauenheilkd 1988; 48:397.
207 207. Chadefaux B, Ceballos I, Rabier D, et al. Prenatal diagnosis of argininosuccinic aciduria by assay of argininosuccinate in amniotic fluid at the 12th week of gestation. Am J Med Genet 1990; 35:594.
208 208. Fernandez de Castro A, Usategui‐Gomez M, Spellacy WN. Amniotic fluid amylase. Am J Obstet Gynecol 1973; 116:931.
209 209. Dawood MY. Hormones in amniotic fluid. Am J Obstet Gynecol 1977; 128:576.
210 210. Madazli R, Atis A, Uzun H, et al. Mid‐trimester amniotic fluid angiogenin, lactate dehydrogenase and fibronectin in the prediction of preterm delivery. Eur J Obstet Gynecol Reprod Biol 2003; 106:160.
211 211. Cohen SB, Goldenberg M, Rabinovici J, et al. Anticardiolipin antibodies in fetal blood and amniotic fluid derived from patients with the anti‐phospholipid syndrome. Hum Reprod 2000; 15:1170.
212 212. Pacsa AS. Impairment of immunity during pregnancy and antiviral effect of amniotic fluid. Lancet 1977; 1:330.
213 213. Fainaru M, Deckelbaum R, Golbus MS. Apolipoproteins in human fetal blood and amniotic fluid in midtrimester pregnancy. Prenat Diagn 1981; 1:125.
214 214. Ruelland A, Mention JE, Perrot Y, et al. Evolution du taux de l'apolipoproteine A dans le liquide amniotique au cours de la grossesse normale et pathologique [The levels of apolipoprotein A in liquor in normal and pathological pregnancies (author's transl.)]. J Gynecol Obstet Biol Reprod (Paris) 1982; 11:241.
215 215. Chadefaux‐Vekemans B, Rabier D, Cadoudal N, et al. Prenatal diagnosis of some metabolic diseases using early amniotic fluid samples: report of a 15 years, experience. Prenat Diagn 2006; 26:814.
216 216. Borresen AL, van der Hagen CB. Metachromatic leukodystrophy. II. Direct determination of arylsulphatase A activity in amniotic fluid. Clin Genet 1973; 4:442.
217 217. Di Lieto A, Pollio F, Catalano D, et al. Atrial natriuretic factor in amniotic fluid and in maternal venous blood of pregnancies with fetal cardiac malformations and chromosomal abnormalities. J Matern Fetal Neonatal Med 2002; 11:183.
218 218. Lewis JF, Johnson P, Miller P. Evaluation of amniotic fluid for aerobic and anaerobic bacteria. Am J Clin Pathol 1976; 65:58.
219 219. Prevedourakis C, Koumentakou E, Zolotas J, et al. E. coli growth inhibition by amniotic fluid. Acta Obstet Gynecol Scand 1976; 55:245.
220 220. Ford LC, DeLange RJ, Lebherz TB. Identification of a bactericidal factor (B‐lysin) in amniotic fluid at 14 and 40 weeks'
